Chemical Genomics
Our team at Genea Biocells was one of the first to systematically use high-throughput screening to modulate pluripotency maintenance and differentiation of stem cells. We developed a monolayer culture method for human pluripotent stem cells in 2008 to enable efficient high-content imaging – our primary technology for drug screening, optimization of culture processes and aspects of quality control testing. Our medicinal chemistry platform...
